Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Some 20% of those with NAFLD also showed signs of liver fibrosis.
People treated with direct-acting antivirals had a lower risk for liver failure and liver cancer as well as much lower mortality.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Even though as many as 97% of patients can be cured with medication, many still don’t receive the treatment.
Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.
People who achieved SVR two or more years ago were less likely to develop hepatocellular carcinoma than those cured more recently.
Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.
Stephan Urban, PhD, developed a drug that blocks hepatitis B and D from entering liver cells.
People with a tendency to be active later in the day may be at greater risk for severe NAFLD.
The antiviral treatment is safe and effective for pediatric patients ages 12 and up.
Non-alcoholic fatty liver disease is substantially more common among men compared with women.
People with NAFLD who had heart disease or had a stroke had higher rates of dementia.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.